← Back to headlines
Health Insurers Question Medicare GLP-1 Program, Causing Pharma Stock Drops
Health insurers are raising questions about a new Medicare program that will offer GLP-1 medications to seniors for $50 per month, leading to a drop in shares for pharmaceutical companies like Novo Nordisk and Eli Lilly amid concerns over coverage plans.
21 Apr, 16:11 — 21 Apr, 17:54
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left
Center1
Center (1)
marketwatch
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
marketwatchMostly Factual1h ago
Health insurers raise questions about Medicare program that will offer GLP-1s to seniors for $50
Some health insurers are pushing back against a new program that will allow Medicare beneficiaries to pay $50 per month for GLP-1 medications for weight loss.
By Jaimy Lee
Read full article →seeking-alphaMixed3h ago
Novo, Lilly drop as insurers are wary of joining Medicare GLP-1 coverage plan
Read full article →Coverage Timeline
First report: seeking-alpha · 21 Apr, 16:11|Full coverage: 2 · 2h|Window: 2h
Left-leaningCenterRight-leaning